EMRMEDIUM SIGNALFINANCIAL10-K

Emerson completed its $7.2 billion acquisition of the remaining AspenTech shares, creating significant balance sheet changes including substantially higher current liabilities and increased debt levels.

The AspenTech acquisition transforms Emerson into a "global automation leader" but comes with considerable financial impact, requiring substantial funding that has altered the company's capital structure. The transaction appears to be part of a broader strategic repositioning toward higher-growth, higher-margin industrial technology markets.

Comparing 2025-11-10 vs 2024-11-12View on EDGAR →
FINANCIAL ANALYSIS

The AspenTech acquisition drove substantial increases in current liabilities (up 70.6%) while total debt grew 16.1%, indicating the company used a mix of debt and working capital financing for the deal. Cash declined 29% and current assets fell 15.8%, reflecting the significant capital deployment, though net income grew a solid 16.5% showing the underlying business remains profitable. The balance sheet changes reflect a major strategic transaction rather than operational deterioration, but investors should monitor debt service capacity and integration execution.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
+70.6%
$5.7B$9.8B

Current liabilities surged 70.6% — significant near-term obligations; verify ability to meet short-term debt.

Cash & Equivalents
Balance Sheet
-29%
$3.3B$2.4B

Cash decreased 29% — monitor burn rate and upcoming capital needs.

Net Income
P&L
+16.5%
$2.0B$2.3B

Net income grew 16.5% — bottom-line growth signals improving overall business health.

Total Debt
Balance Sheet
+16.1%
$7.7B$8.9B

Debt rose 16.1% — additional borrowing for investment or operations; monitor coverage ratios.

Current Assets
Balance Sheet
-15.8%
$10.2B$8.6B

Current assets declined 15.8% — monitor working capital adequacy and short-term liquidity.

LANGUAGE CHANGES
NEW — 2025-11-10
PRIOR — 2024-11-12
ADDED
Common stock outstanding at October 31, 2025 : 561.8 million shares.
("Emerson", "we", "us", "our" or the "Company ) is a global technology and software company that provides innovative solutions for customers in a wide range of end markets around the world.
Sales by geographic destination in 2025 were: the Americas, 51 percent; Asia, Middle East Africa, 30 percent (China, 10 percent); and Europe, 19 percent .
These actions were undertaken to create a cohesive, higher growth, higher margin industrial technology portfolio, and the Company is now a global automation leader serving a diversified set of end markets.
The Company s recent portfolio actions include the following transactions (note that all d ollars in Item 1 are in millions, except where noted) : On March 12, 2025, Emerson completed its purchase of the remaining outstanding shares of common stock of AspenTech not already owned by the Company for approximately $7.2 billion.
+7 more — sign up free →
REMOVED
Common stock outstanding at October 31, 2024 : 570.2 million shares.
PART I ITEM 1 - BUSINESS Emerson ( the Company ) is a global technology and software company that provides innovative solutions for customers in a wide range of end markets around the world.
Sales by geographic destination in 2024 were: the Americas, 50 percent ; Asia, Middle East Africa, 30 percent (China, 11 percent ); and Europe, 20 percent .
The Company s recent portfolio actions include the following transactions (note that all d ollars in Item 1 are in millions, except where noted) : On October 11, 2023, the Company completed the acquisition of National Instruments Corporation ("NI") at an equity value of $8.2 billion.
On May 31, 2022 the Company completed the divestiture of its Therm-O-Disc sensing and protection technologies business to an affiliate of One Rock Capital Partners, LLC.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →